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ABSTRACT
The present study examined some neuropsychological profiles of cannabis dependent 
users on long abstinence in Nigeria. Ninety participants were recruited for the study. 
Their ages ranged from 27 – 35 years with a mean age of 30.78. Five neuropsychological 
instruments were used for the study: Symbol Digit Modality Test (SDMT), Digit Symbol 
Modality Test (DSMT), Trail Making Tests A & B (TMT – A/B), Rey Auditory Verbal Learning 
Test (RAVLT) and Rivermead Post Concussion Syndrome questionnaire (RPC). The findings 
of the study showed significant differences on verbal learning; RAVLT Trial 5: F(2,81) = 
15.20, RAVLT Total Trial: F(2,81) = 11.06, Delayed verbal memory, F(2,81) = 10.94 all 
at P ≤ 0.05 level of testing with cannabis users performing worse than the psychiatric 
and healthy controls. Significant differences were also seen on processing speed: DSMT: 
F(2,81) = 3.53 with cannabis users performing worse than the healthy control but better 
than the psychiatric group. Drug users had significant less performance than the healthy 
control on TMT A; F(2,81) = 8.04 and TMT B; F(2,81) = 7.41 as measures of executive 
function. Also, drug users had significant worse complaints of somatic, cognitive and 
emotional symptoms following brain injury as measured by RPC; F(2,81) = 7.11 all at 
P ≤ 0.05 level of testing. Discussions of the study was based upon long term effects 
of cannabis use on neuro-cognition even after prolonged abstinence and reasons for 
the mixed findings surrounding this area of study. Implications of the study were also 
examined.
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INTRODUCTION
Addiction is generally defined as com-
pulsive and persistent use of drugs despite 
negative consequences (Pascoli, Terrier, 
Hiver & Cuscher, 2015). Ideally depen-
dent drug users will continue drug con-
sumption despite negative consequences 
typically related to social and psychologi-
cal defects that are often delayed in time 
(Pascoli et al., 2015). Neurobiological ex-
planations of addiction have shown vari-
ous areas of the brain to be involved in 
compulsive drug seeking. Pascoli et al. 
(2015) using optogenetic self stimulation 
show that the Dopamine (DA) neurons of 
the ventral tegmental area (VTA) are im-
plicated in drug addiction. Consequently 
their study implicated the D1 receptor ex-
pressing neurons of the nucleus acubems 
(NAc) as involved in cue induced relapse 
after weeks of abstinence while resistant 
to punishment was associated with en-
hanced neural activity in the orbitofrontal 
context (OFC) of mice addicted to drugs. 
In humans similar neural areas have been 
identified as addictive brain areas. Everitt 
and Robbins (2016) described the transi-
tion from ventral to dorsal striatum involv-
ing the DA neurons as major pathways of 
drug use to drug compulsion. Taken to-
gether all the evidences on drug addiction 
based on neurobiology, it becomes clear 
that neural plasticity occurs during addic-
tion and such plasticity accounts for drug 
addiction.
Aside the neural plasticity leading to 
addiction, drug users also show relative 
cognitive impairments (Cadet & Bisagno, 
2016). Accumulating evidence suggests 
that dependent and recreational cocaine 
use is associated with broad neuropsy-
chological impairments (Goldstein, Les-
kovjan, Hoff, Hitzeman, Bashen, Khalsa & 
Colleagues, 2004; Jovanovski, Erb & Zak-
zanis, 2005; Vonmoos, Hulka, Preller, Jen-
ni, Baumgaitner, Stohler et al, 2013; Soar, 
Mason, Potton & Dawkins, 2012). 
Vonmoos, Hulka, Preller, Mander, 
Baungartner and Quednow (2014) stud-
ied cognitive impairment in cocaine users 
and its possible reversibility. Their findings 
showed that increased cocaine use within 
1 year was associated with reduced cogni-
tive performance primarily in the working 
memory. By contrast, decreased cocaine 
use was linked to small cognitive improve-
ments in all domains studied (attention, 
working memory, declarative memory 
and executive functions). Importantly, us-
ers who ceased taking cocaine seemed 
to recover completely, attaining a cogni-
tive performance level similar to that of 
control group. In addition, recovery of 
working memory showed correlation 
with the age of onset with early onset us-
ers showing hampered recovery. Studies 
have shown deficits in attention, work-
ing memory and declarative memory in 
chronic cocaine users whereas the het-
erogeneous concept of executive func-
tions have yielded mixed results (Java-
novski, et al. 2005; Vonmoos et al. 2013). 
Other studies have equally demonstrated 
that cocaine users additionally display in-
ferior social cognition including prosodic 
and cross modal emotion recognition, 
emotional empathy, mental perspective 
taking and social decision making (Hulker, 
Eisenegger, Preller, Vonmoos, Jenni, Ben-
drick and Colleagues, 2014; Hulker, Prel-
ler, Vonmoos, Broicher & Quednow, 2013; 
Preller, Hulka, Vonmoos, Jenni, Baungart-
ner, Oziobek and Colleagues, 2014).
Becker, Collins, Schultz, Urosevic, 
Schmaling and Luciana (2018) stud-
ied longitudinal changes in cognition in 
young adult cannabis users. Their study 
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examined associations between chronic 
use (CU) and cognition over time in chron-
ic daily adolescent onset chronic users 
(CUs) as compared to normal controls. 
Both groups completed a neuropsycho-
logical battery at study intake and again 
2 years later. Their baseline group differ-
ences indicated deficits in verbal learning 
and memory, motivated decision making, 
planning and working memory in CUs. At 
the longitudinal follow-up, the majority of 
Cus continued to report regular and heavy 
cannabis use. Relative impairments in the 
domains of working memory, planning 
and verbal memory remained stable sug-
gesting that these are enduring vulnerabil-
ities associated with continued CU during 
young adulthood. However impairments 
in motivated decision making were evi-
dent in both groups. In addition, CUs dem-
onstrated relatively better performance 
in short duration speeded tasks, while an 
earlier age of CU onset was associated with 
poorer verbal learning and memory and 
planning performance over time. Other 
studies have equally supported the effects 
of cannabis on neurocognitive functions 
both the acute (Grady, 1999; Morrison, 
2015; Mckeown, Lee, Holt, Powell, Kapur 
& Murray, 2009) and residual effects of 
cannabis (Herman, Sartorius, Welzel, Wal-
ter, Skopp, Ende & Mani, 2007; Solowji, 
Stephens, Roffman, Bator, Kadden, Miller, 
Christiaonsen, McRee, Vendetts, 2002).
Crean, Crane and Mason (2011) re-
viewed some evidence of long term ef-
fects of cannabis use on executive cogni-
tive functions. According to the authors 
this area of research has been fraught 
with inconsistencies in findings and is 
complicated by discrepant definition of 
what constitutes long term effects. Cre-
an et al asserted that only a handful of 
researchers have examined the long term 
effects of cannabis use in executive func-
tions. In seven studies reviewed by Crean 
et al. (2011), five found no attention or 
concentration impairments in partici-
pants who had remained abstinent from 
28 days to one year (Lyons, Bar, Paniz-
zon, Toomey, Eisen, Xian & Tsuang, 2004; 
Pope, Gniber, Hudson, Huestis, Yurgelun–
Toos, 2001, 2002, 2003, Verdejo-Garcia, 
Lopez–Torrecillas, Aguillar de Arcos, Per-
ez-Garcia, 2005). Other areas of neuro-
psychological abilities have equally been 
examined among abstinent cannabis us-
ers including working memory, verbal flu-
ency, inhibition and impulsivity, decision 
making and risk taking (see Crean et al 
2011 for exhaustive discussion). Overall 
cannabis appears to continue to exert 
impairing effects in executive functions 
even after 3 weeks of abstinence and be-
yond. While basic attentional and work-
ing memory abilities are largely restored, 
the most enduring and detectable deficits 
are seen in decision making, concept for-
mation and planning (Crean et al 2011).
The present study was on examina-
tion of some neuropsychological abilities 
among cannabis users in a rehabilitation 
centre in Anambra State. The neurocogni-
tive abilities examined were verbal learn-
ing/memory, processing speed and exec-
utive functions of the participants. To the 
researchers best of knowledge, no studies 
have been carried out in Nigeria on neu-
ropsychological profiles of cannabis users 
particularly those on abstinence for over 
3 months. The problems of paucity of lit-
erature on this area of long term cognitive 
effects of cannabis following abstinence 
may affect post detoxification manage-
ment. Crean et al (2011) had earlier stat-
ed the benefits of neurocognitive assess-
ment on rehabilitation of drug addicts. 
The gap in knowledge and treatment 
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created by such lack of studies on neuro-
cognition of cannabis dependents is what 
the present study seeks to fill.
Thus the following hypotheses were 
proposed to guide the research:
i. Cannabis users on abstinence will dif-
fer significantly on verbal learning and 
memory from healthy controls and 
psychiatric patients. 
ii. Cannabis users on abstinence will dif-
fer significantly from the healthy con-
trols and psychiatric patients on test 
of processing speed.
iii. Cannabis drug users will differ signifi-
cantly from health control and psy-
chiatric patients on test of executive 




Ninety participants took part in the 
study. They were recruited from the 
population of psychiatric patients, drug 
users and healthy controls. The psychi-
atric samples were thirty (30) inpatients 
recruited from the government neuropsy-
chiatric hospital in Anambra State Nige-
ria. They included 22 males and 8 females 
diagnosed with psychotic disorders by 
the attending psychiatrists. The psychiat-
ric group was receiving treatment in the 
mental health facility during the study. All 
the participants were on newer forms of 
antipsychotic medications as at the time 
of the study and have stayed in the hos-
pital for at least 3 months. On the other 
hand, the drug users were recruited from 
the inpatient rehabilitation facility owned 
by the Nigeria Drug Law Enforcement 
Agency in Anambra State. They included 
30 participants identified to be cannabis 
users. Twenty five (25) of the participants 
reported that they also take codeine and 
alcohol and sparingly cocaine. However 
the predominant drug of usage was can-
nabis. All the cannabis participants re-
ported that they had had used cannabis 
for over 5 years and had for the past one 
year been using cannabis on a near daily 
basis. The reason for choosing the Drug 
Rehabilitation centre was its strict rules 
on inpatient admission. Patients are not 
allowed to assess drugs neither were 
there rooms for drug smuggling into the 
patients’ wards. This to a large extent as-
sures abstinence as soon the drug user 
is still in admission. The normal controls 
were recruited from the population of 
undergraduate students and secondary 
school leavers who reported no use of 
drugs (cannabis, cocaine, codeine, trama-
dol, etc.) and no symptoms of psychotic 
disorder based on Symptom Checklist 90 
R self report. They were matched on age 
and education with the addiction group.
Table 1 shows no significant differences 
among the groups on age and length of 
education respectively.
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Table 1. Summary Table of Education and Age of the Participants
Group Mean Age Mean Length of Education F (age) F (edu)
Drug users 30.52 7.65
Psychiatric patients 31.68 7.08 0.85a 1.34a
Normal Controls 30.75 8.03
a = No Significant difference at P ≤ 0.05.
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Instrument
Five neuropsychological tests were 
used in the study. The Symbol Digits 
Modalities Test (SDMT, Smith, 1991) is a 
speeded task that has been used exten-
sively with diverse clinical groups for the 
assessment of processing speed (Martin & 
Bush, 2008). This requires an examinee to 
look at a series of nine geometric figures 
that have each been paired with a num-
ber. The test items present the geometric 
figures that have each been paired with a 
number. Test items present the geometric 
figure only and the examinee must quickly 
write in the target number that goes with 
each figure (Martin & Bush, 2008). The 
score is the number of correct substitu-
tion completed within 90 seconds. How-
ever the present study allowed the par-
ticipants to work as fast as they could and 
the score was the time it took the partici-
pants to complete the task. Similar to the 
SDMT was the Digit Symbol Modality Test 
(DSMT). The DSMT (WAIS III: Psychologi-
cal Corporation, 1957) shares the same 
features with the SDMT other than the ex-
aminee looks at a series of nine numbers 
that have each been paired with a geo-
metric figure. In DSMT, test items present 
the numbers only and the examinee must 
quickly write in the target figures that go 
with each number (Lezak, et al 2012). The 
Trial Making Test (TMT; Army Individual 
Test Battery, 1944) is a commonly used 
neuropsychological assessment instru-
ment (Arbuthnott & France, 2000; Reitan 
& Wolfson, 1983) that consists of two 
subtests. TMT – A involves drawing a line 
that connects consecutive numbers from 
1 to 25 while TMT – B involves drawing a 
line connecting alternating numbers and 
letters in sequence (1 – A – 2 – B etc). 
Traditional scoring is the time in seconds 
required to complete each part of the 
test. The present study included the num-
ber of errors made on the task. The TMT 
provides information regarding atten-
tion, visual scanning, speed of eye-hand 
coordination and information processing 
(Miltrushina, Boone & D’Etia, 1999). The 
Rey Auditory Verbal Learning Test (RAVLT) 
affords an analysis of learning and reten-
tion. It involves a five-trial presentation of 
a 15 – word list (List A), a single presen-
tation of an interference list (List B), two 
post interference recall trials (one imme-
diate, one delayed) and recognition of the 
target words presented with distracters 
(RWL) (Lezak, Howieson, Bigler & Tranel 
(2012). RAVLT has been shown to be re-
liable and valid in neuropsychological as-
sessment of memory in various disorders 
including multiple sclerosis (Brown, Kin-
sella, Ong & Volvels, 2000) and Alzheimer 
type dementia (Bigger, Rosa, Schultz et al, 
1989, Ferman, Smith, Boone et al, 2006). 
RAVLT has been shown to have adequate 
reliability and divergent validation using 
Nigeria samples (Ucheagwu, Ugokwe-Os-
sai, Okpaleke & Ugokwe, 2017). The Riv-
ermead Post Concussion Symptoms ques-
tionnaire (King, Crawford, Wenden, Moss 
& Wade, 1995) is designed to assess the 
presence and severity of post concussion 
syndrome (PCS) which is a set of somatic, 
cognitive and emotional symptoms fol-
lowing traumatic brain injury. The authors 
show that RPQ had good reliability both 
for test – retest and inter-rater reliability. 
Procedure
The psychiatric sample were tested in 
the psychiatric hospital where they were 
inpatients receiving treatment. All the 
psychiatric participants were taking new-
er forms of antipsychotic medication. Be-
cause of their medication, they were all 
tested in the afternoon. This was to allow 
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for sometime after taking the medication 
the previous night. Because of antipsy-
chotic side effects, some patients eligible 
for the study did not participate. Only 
patients that reported no or fewer signs 
of motor retardation and dizziness were 
recruited for the study. They were tested 
individually after adequate rapport and 
written consent were obtained from the 
patients and care-givers respectively. Con-
versely the drug users were equally test-
ed at the drug rehabilitation centre where 
they were admitted for rehabilitation. As 
at the time of the study, none of the par-
ticipants were on antipsychotics. The only 
medication known to be administered 
was multivitamins. The drug addicts were 
tested individually after adequate con-
sent was obtained from the participants 
and authorities of the rehabilitation cen-
tre. The normal controls were invited to 
the psychology laboratory of the univer-
sity (Lead Author’s University) where they 
were equally tested individually after ob-
taining written consent from the partici-
pants. The research ethical committee of 
the Madonna University Department of 
Psychology approved the study which fol-
lows the Helsinki declaration on involve-
ment of human participants in research.
Design and Statistics
The between group design was used 
for the study while the multivariate analy-
sis of variance was used for data analysis.
RESULTS
The statistical estimations were to es-
tablish neuropsychological differences 
among cannabis drug dependents, psy-
chiatric patients and healthy controls. 
The analysis did not include the female 
participants because only eight partici-
pants were involved and they were from 
the psychiatric group only.
The findings of the study showed signif-
icant differences on the Rivermead Post 
Concussion Questionnaire (RPQ) F(2, 81) 
= 7.11 at P ≤ 0.001, RAVLT Trial 5: F(2, 81) 
= 15. 20 at P ≤ 0.001; RAVLT Total Trial: 
F(2, 81) = 11.06 at P ≤ 0.001; RAVLT In-
terference: F(2, 81) = 7.89 at P ≤ 0.001; 
RAVLT Delayed Trial: F(2, 81) =10.94 at P 
≤ 0.001; TMT A (TIME) F(2, 81) = 8.04 at P 
≤ 0.001; TMT B (TIME) F(2,81) = 7.41 at P 
≤ 0.001; TMT A (ERROR) F(2, 81) = 25.21 
at P ≤ 0.001; TMT B (ERROR) F(2, 81) = 
7.46 at P ≤ 0.01; SDMT: F(2, 81) = 10.68; 
DSMT: F(2, 81) = 3.53 at P ≤ 0.03. How-
ever no significant differences were seen 
on RAVLT Trial 1 and RAVLT Recognition at 
P ≤ 0.005 respectively. 
Table 2 shows the mean scores of the 
groups as they reflect the neuropsycho-
logical behaviours. Equally Table 3 shows 
the pair wise comparisons of the 3 groups 
on neuropsychological behaviours that 
show significant differences.
DISCUSSION
The findings of the study showed sig-
nificant differences among the groups 
studied on verbal memory and learn-
ing using the Rey Auditory verbal learn-
ing test (RAVLT). Trial 5 of the RAVLT has 
been shown to identify the number of 
words learnt during the verbal learning 
tasks (Lezak et al, 2012). The analysis of 
the present data showed that cannabis 
users on abstinence had the least score 
on verbal learning and pair wise com-
parisons of the three groups showed sig-
nificant learning differences between the 
cannabis addicts on one hand and health 
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Table 2. Mean Scores of Neuropsychological Profiles of the Participants
Dependent Variable Mean Std Error
RPQ
Psychiatric patients 17.15 2.06
Drug Users 26.04 1.96
Normal 16.87 1.10
RAVLT Trial 1
Psychiatric patients 6.62 0.51
Drug Users 5.77 0.49
Normal 6.95 0.47
RAVLT Trial 5
Psychiatric Patients 9.08 0.54
Drug Users 5.62 0.51
Normal 9.07 0.50
RAVLT Total Trial
Psychiatric Patients 39.63 2.13
Drug Users 28.07 2.02
Normal 39.77 1.95
RAVLT Interference 
Psychiatric Patients 7.75 0.59
Drug Users 5.40 0.56
Normal 8.35 0.54
RAVLT Delayed Trial 
Psychiatric Patients 7.84 0.57
Drug Users 4.83 0.54
Normal 7.96 0.52
RAVLT Recognition Trial 
Psychiatric Patients 14.08 0.66
Drug Users 12.67 0.63
Normal 12.62 0.61
TMT A (TIME)
Psychiatric Patients 112.27 9.07
Drug Users 109.19 8.61
Normal 68.87 8.33
TMT B (TIME)
Psychiatric Patients 168.68 13.35
Drug Users 156.51 12.67
Normal 103.91 12.26
TMT A (ERROR)
Psychiatric Patients 0.15 0.91
Drug Users 0.82 0.08
Normal 0.14 0.08
TMT B (ERROR)
Psychiatric Patients 3.34 0.66
Drug Users 2.50 0.62
Normal 0.06 0.60
SDMT
Psychiatric Patients 371.29 22.45
Drug Users 255.35 21.31
Normal 238.17 20.63
DSMT
Psychiatric Patients 326.37 51.55
Drug Users 300.32 48.92
Normal 156.43 47.35
controls and psychiatric patients on the 
other hand. Equally the RAVLT total trial 
score (ie: scores total scores of trials 1-5 
of the RAVLT) showed that cannabis ad-
dicts performed significantly worse than 
the other 2 groups. 
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This finding show that cannabis us-
ers on abstinence for over 3 months still 
show impairments on verbal learning 
performance. Previous studies show ver-
bal impairment in cannabis chronic us-
ers when compared with health control 
(Becker et al 2018) both at acute intoxica-
tion and long term chronic use. However 
studies relating to abstinence of heavy 
chronic users show that at 28 days, no 
difference is seen between chronic users 
on abstinence and control group (non 
heavy users) on verbal fluency and ver-
bal information (Pope et al, 2001, Crean 
et al., 2011). These findings were in con-
trast with our present finding that chron-
ic heavy users on abstinence for over 3 
months still showed impairment on ver-
bal learning. However differences may 
be as a result of diverse neuropsycho-
logical tests used by various researchers. 
The present study used the RAVLT while 
Pope et al study used measures dealing 
more on verbal fluency. Equally previous 
studies recruited cannabis users (light 
users) as control group while our con-
trol groups were persons that were can-
nabis naive. This may have contributed 
to differences in our findings. Thus our 
findings showed relative lasting residu-
al effect of cannabis on verbal learning 
even after 3 months of abstinence. Con-
versely, the same significant difference 
was observed on delayed task of RAVLT 
which measures verbal memory. Can-
nabis users on abstinence still showed 
significant poor performance than other 
groups on delayed verbal memory task 
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Table 3. Summary Table of Pair Wise Comparison 
Defendant Variable Group Group Diff Sig. 
RPQ
Normal Psychiatric Patients -0.28 0.92
Drug Users -9.17 0.001
RAVLT Trial 5
Normal Psychiatric Patients -.013 0.97
Drug Users 3.45 0.001
RAVLT Total Trial 
Normal Psychiatric Patients 0.14 0.96
Drug Users 11.70 0.001
RAVLT Interference
Normal Psychiatric Patients 0.61 0.45
Drug Users 2.96 0.001
RAVLT Delayed Trial
Normal Psychiatric Patients 0.12 0.86
Drug Users 3.13 0.001
TMT A (TIME)
Normal Psychiatric Patients -43.40 0.001
Drug Users -40.32 0.001
TMT B (TIME)
Normal Psychiatric Patients -64.77 0.001
Drug Users -52.64 0.004
TMT A (ERROR)
Normal Psychiatric Patients 0.15 0.24
Drug Users -0.67 0.001
TMT B (ERROR)
Normal Psychiatric Patients -3.28 0.001
Drug Users -2.43 0.005
SDMT
Normal Psychiatric Patients -133.12 0.001
Drug Users -17.19 0.56
DSMT
Normal Psychiatric Patients -169.94 0.02
Drug Users -143.89 0.04
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of RAVLT. Our finding was in line with 
those of Solowji et al. (2002) and Solowji 
and Battisti, (2008), who showed that 
long term cannabis users performed sig-
nificantly less well than the short term 
users and controls on tests of memory 
and attention using the RAVLT and time 
estimation tasks. According to them long 
term users show impairments in memo-
ry and attention with increasing years of 
regular cannabis use. However our study 
was little different from theirs because 
our cannabis participants were abstinent 
for over 3 months but still showed de-
creased verbal memory when compared 
with healthy controls.
On the other hand, significant differ-
ences were only seen on the process-
ing speed performance using the digit 
symbol modality test (DSMT) between 
the healthy controls and cannabis par-
ticipants. Importantly cannabis users 
performed better than the psychiatric 
participants on DSMT and also on an-
other task of processing speed the sym-
bol digit modality test (SDMT). Similarly 
cannabis users show significantly less 
performance than the healthy controls 
on measures of executive functions us-
ing the TMT A and B. Mixed findings have 
trailed the residual effects of cannabis on 
executive function following some days 
(maximum 20 days) of abstinence. Pope 
et al (2001, 2002) as well as Jager, Kahn, 
Ven Den Broken Van Reea and Ramsey 
(2006) on all five studies found no signifi-
cant differences on executive functions 
of heavy cannabis users, former heavy 
cannabis users and control subjects on 28 
days abstinence. Contrary to this, Solowy 
et al (2002) and Herman et al (2007) re-
ported positive significant differences on 
abstinence between chronic users and 
healthy controls. These differences may 
as well be attributed to the nature of 
neuropsychological tests used to assess 
executive functioning, the nature of par-
ticipants recruited for the study as well 
the length of abstinence.
Implication for Treatment 
Cognitive impairments have been 
generally associated with poorer drug 
abuse treatment outcome (Aharonovich, 
Brooks, Nunes & Hasin, 2008; Abboth & 
Gregson, 1981) and those impairments 
have been found to impede acquisition 
of new coping behaviours (McCrady & 
Smith 1986), learning and retention of 
new material (Alternman & Hall, 1989) 
and also increases the likelihood of 
treatment dropouts (Teichner, Horner, 
Routzch, Herron & Theros, 2002). This 
suggests that incorporating the standard 
cognitive remediation into the rehabilita-
tion of cannabis users will optimize treat-
ment outcome. It is therefore important 
to equally include standard neuropsycho-
logical assessment in the protocols for 
assessment and treatment of cannabis 
dependent users. 
Since the present study suggests long 
term effects of cannabis use on neuro-
cognition, intermediate neuropsychologi-
cal assessment of cannabis users under 
rehabilitation will help determine can-
nabis users still affected with cannabis 
neuro-cognitive effects over long term re-
habilitation and abstinence and possibly 
improve on their neuro remediation. 
Our present study has certain limita-
tions. We were not able to divide the 
cannabis users into months of abstinence 
like 3 months, 5 months, 1 year, although 
all our participants have had at least 3 
months of abstinence and were still in 
the rehabilitation centre. Future studies 
including different abstinence time may 
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further tell us more about abstinence 
and neuro-cognition. Although our pres-
ent study to the author’s best of knowl-
edge was the first to assess the neuro-
cognitive status of cannabis users on 3 
months of abstinence in a rehabilitation 
centre, we believe that neuro-plasticity 
following cannabis use may still improve 
based upon time. Equally our study failed 
to categorize the users under duration 
of exposure and quantity of cannabis 
abused. However, we reported that all 
participants had used cannabis for over 
5 years prior to admission and based 
upon self report have been using canna-
bis on everyday basis at least 1 year be-
fore admission into rehabilitation. These 
description criteria have ideally covered 
bases for dependence and heavy use, but 
further categorization could have given 
more credence to the study. Equally we 
did not involve any biological test to en-
sure total abstinence among the drug ad-
dicts. We had simply relied on the nature 
and security of the centre for abstinence. 
Future studies involving such measures 
will give better credence to the results 
obtained.
Psychiatric patients were included into 
the study also as a form of control to the 
cannabis participants. Some cannabis us-
ers from clinical experience show some 
signs of psychotic features when first ad-
mitted in a rehabilitation centre. This was 
also reported in 25 participants from our 
study. Thus to cushion the effect of psy-
chotic features on the findings, we decid-
ed to recruit the psychiatric participants 
with psychotic features under remission 
undergoing psychiatric rehabilitation. 
Overall, our study shows that cannabis 
users have impairments in verbal learn-
ing and memory when compared to 
healthy and psychiatric controls. Equally 
they showed significant impairment in 
processing speed and executive functions 
when compared with the healthy control 
but performed better than the psychiatric 
participants. 
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